PetIQ Inc (PETQ)
17.09
+0.25
(+1.48%)
USD |
NASDAQ |
May 03, 11:49
PetIQ Total Liabilities (Quarterly): 645.23M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 645.23M |
September 30, 2023 | 617.92M |
June 30, 2023 | 647.87M |
March 31, 2023 | 644.57M |
December 31, 2022 | 607.10M |
September 30, 2022 | 576.40M |
June 30, 2022 | 587.59M |
March 31, 2022 | 663.28M |
December 31, 2021 | 564.37M |
September 30, 2021 | 563.37M |
June 30, 2021 | 573.63M |
March 31, 2021 | 595.82M |
December 31, 2020 | 525.18M |
September 30, 2020 | 476.13M |
June 30, 2020 | 503.94M |
Date | Value |
---|---|
March 31, 2020 | 445.49M |
December 31, 2019 | 344.42M |
September 30, 2019 | 354.21M |
June 30, 2019 | 185.67M |
March 31, 2019 | 206.67M |
December 31, 2018 | 174.46M |
September 30, 2018 | 170.91M |
June 30, 2018 | 190.85M |
March 31, 2018 | 202.09M |
December 31, 2017 | 36.00M |
September 30, 2017 | 36.74M |
June 30, 2017 | 52.52M |
March 31, 2017 | 61.31M |
December 31, 2016 | 40.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
185.67M
Minimum
Jun 2019
663.28M
Maximum
Mar 2022
532.75M
Average
573.63M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
Dynavax Technologies Corp | 375.02M |
Pacira BioSciences Inc | 704.26M |
Supernus Pharmaceuticals Inc | 356.16M |
Esperion Therapeutics Inc | 660.79M |
Deciphera Pharmaceuticals Inc | 122.65M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 868.23M |
Shareholders Equity (Quarterly) | 221.21M |
Debt to Equity Ratio | 2.018 |
Current Ratio | 2.273 |
Net Debt Paydown Yield | 0.23% |